Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycyrrhizinate (also known as glycyrrhizin or glycyrrhizic acid) is a triterpenoid saponin compound extracted from the root of licorice (Glycyrrhiza species). It is widely used for its anti-inflammatory, antiviral, hepatoprotective, and immunomodulatory properties. Glycyrrhizinate exerts its effects by suppressing pro-inflammatory cytokines such as TNF-alpha and caspase 3, inhibiting the nuclear translocation of NF-κB, conjugating free radicals, and modulating immune cell proliferation via JNK, ERK and PI3K/AKT pathways. Its antiviral activity includes inhibition of viral replication across a broad spectrum of viruses. Clinically in China and other countries it is used primarily for liver diseases (such as hepatitis), inflammatory conditions including inflammatory bowel disease, allergic disorders, peptic ulcers and to protect against drug-induced liver injury[1][4][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycyrrhizinate.